Availability of Interaction Profile for Chlorinated Dibenzo-p -Dioxins, Polybrominated Diphenol Ethers, and Phthalates, 63981-63982 [2013-25145]
Download as PDF
<![CDATA[
63981
Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices
Comments on the ICR must be
received on or before December 24,
2013.
ADDRESSES: Submit your comments to
Information.CollectionClearance@
hhs.gov or by calling (202) 690–6162.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–6162.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
document identifier HHS–OS–20694–
60D for reference.
Information Collection Request Title:
State Medicaid Fraud Control Units’
Reports.
OMB No.: 0990–0162.
Abstract: Office of Inspector General
(OIG) is requesting an extension by
Office of Management and Budget
(OMB) of approval for the collection of
information to comply with the
requirements in Title 19 of the Social
Security Act at 1903(q), 42 CFR 1007.15,
and 42 CFR 1007.17, in accordance with
the Paperwork Reduction Act. The
information collected consists of fifty
separate annual reports and fifty
separate application requests for
certification/recertification of State
Medicaid Fraud Control Units (MFCU).
The collection is required by the statute
DATES:
and submitted yearly to OIG by the fifty
MFCUs. OIG uses the information
collected to determine the MFCUs’
compliance with Federal requirements
and eligibility for continued Federal
financial participation (FFP) under the
Federal MFCU grant program.
Need and Proposed Use of the
Information: Public Law 95–142, the
Medicare-Medicaid Anti-Fraud and
Abuse Amendments, was enacted in
1977 to strengthen the capabilities of
Federal and State governments to
combat and eliminate fraud and abuse
in Medicaid, through the establishment
of the MFCUs. This law amended
section 1903 of the Social Security Act
to establish operating requirements for
MFCUs and provide FFP to State
governments for the cost of establishing
MFCUs, training State personnel, and
keeping the MFCUs operational.
Under section 1903(q)(7), each MFCU
must annually submit to the Secretary of
Health and Human Services (Secretary)
an application and annual report
containing information that the
Secretary determines is necessary to
certify the MFCU as meeting the
requirements for FFP. FFP is available
only for activities directly related to the
investigation and prosecution of health
care providers suspected of committing
Medicaid fraud. The MFCUs also review
complaints of alleged abuse or neglect of
patients and the misuse of patients’
personal funds in health care facilities.
OIG reviews the information collected
to ensure that Federal matching funds
are expended by MFCUs only for
allowable costs. In addition, OIG
analyzes each MFCU’s submission to
determine whether there is a need for
OIG technical assistance and to
establish priorities for onsite reviews to
further monitor program activities.
Likely Respondents: State Medicaid
Fraud Control Units.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Form
MFCU ...............
MFCU ...............
MFCU ...............
Annual Report ...................................................................
Annual Report, data mining reporting only ......................
Recertification Application ................................................
50
13
50
1
1
1
88
1
5
4,400
13
250
Total ...........
emcdonald on DSK67QTVN1PROD with NOTICES
Respondent
...........................................................................................
50
2
94
4,663
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Keith A. Tucker,
Information Collection Clearance Officer.
AGENCY:
[FR Doc. 2013–25187 Filed 10–24–13; 8:45 am]
BILLING CODE 4151–01–P
Agency for Toxic Substances and
Disease Registry
[Docket ATSDR–2012–0002 ATSDR–274]
Availability of Interaction Profile for
Chlorinated Dibenzo-p-Dioxins,
Polybrominated Diphenol Ethers, and
Phthalates
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (DHHS).
Notice of availability for public
comments.
ACTION:
VerDate Mar<15>2010
17:55 Oct 24, 2013
Jkt 232001
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
The Agency for Toxic
Substances and Disease Registry
(ATSDR) within the Department of
Health and Human Services announces
the availability of the interaction profile
for Chlorinated Dibenzo-p-Dioxins,
Polybrominated Diphenol Ethers, and
Phthalates. This interaction profile
evaluates a mixture of chemicals often
found in human blood, adipose tissue,
and breast milk. The purpose of this
interaction profile is to investigate the
possible joint actions of these chemicals
on endocrine, developmental, and
neurobehavioral endpoints in humans.
This interaction profile has undergone
external peer-review and review by
ATSDR’s Interagency Workgroup on
Mixtures.
SUMMARY:
E:\FR\FM\25OCN1.SGM
25OCN1
63982
Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices
The interaction profile was made
available to the public on September 2,
2013. The comment period will end on
December 2, 2013.
ADDRESSES: You may submit comments,
identified by Docket No. ATSDR–2012–
0002, by any of the following methods:
• Internet: Access the Federal
eRulemaking portal at https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Division of Toxicology and
Human Health Sciences, Agency for
Toxic Substances and Disease Registry,
1600 Clifton Road, NE., Mailstop F–57,
Atlanta, Georgia 30333.
Instructions: All submissions received
must include the agency name and
docket number for this notice. All
relevant comments will be posted
without change.
FOR FURTHER INFORMATION CONTACT: Dr.
Hana Pohl, Division of Toxicology and
Human Health Sciences, Agency for
Toxic Substances and Disease Registry,
Mailstop F–57, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, telephone (888)
422–8737.
SUPPLEMENTARY INFORMATION: ATSDR
develops interaction profiles for
hazardous substances found at the
National Priority List (NPL) sites under
Section 104(i)(3) and (5) of the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA). This law
requires that ATSDR assess whether or
not adequate information on health
effects is available for priority
hazardous substances. Where such
information is not available or under
development, ATSDR shall, in
cooperation with the National
Toxicology Program, initiate a research
program to determine these health
effects. The Act further directs that,
where feasible, ATSDR shall develop
methods to determine the health effects
of these priority hazardous substances
in combination with other substances
commonly found with them.
To carry out these legislative
mandates, ATSDR has developed a
chemical mixtures program and
guidance manual that outlines the latest
methods for mixtures health assessment.
In addition, a series of documents called
‘‘interaction profiles’’ is developed for
certain priority mixtures that are of
special concern to ATSDR. To
recommend approaches for the
exposure-based assessment of the
potential hazard to public health, an
interaction profile evaluates data on the
toxicology of the whole priority
mixture, if available, and on the joint
toxic action of the chemicals in the
mixture.
emcdonald on DSK67QTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
17:55 Oct 24, 2013
Jkt 232001
The entire interaction profile
development process is as follows:
• ATSDR selects substances/
chemicals for development of
interaction profiles through inter/intra
agency communications collaboration
and literature reviews.
• After the selection, a letter is sent
to individuals and agencies on ATSDR’s
mailing list providing notice of
ATSDR’s intent to create an interaction
profile.
• A notice is posted in the Federal
Register to inform the public of
ATSDR’s intent to develop a particular
interaction profile.
• The draft interaction profile
undergoes both internal and external
peer review.
• A Federal Register notice
announces the release of the official
draft for public comment.
• ATSDR posts a link to the draft
interaction profile on its Web site,
giving the public an opportunity to
provide comments.
• ATSDR reviews all public
comments and revises the draft, as
appropriate, before issuing the final
version.
Dated: October 18, 2013.
Sascha Chaney,
Acting Director, Office of Policy, Planning
and Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2013–25145 Filed 10–24–13; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 78 FR 58309, dated
September 23, 2013) is amended to
reorganize the Office of Public Health
Preparedness and Response.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Revise the functional statement for
the Office of the Director (CGC1),
Division of State and Local Readiness
(CGC), as follows:
Office of the Director (CGC1). (1)
Provides national leadership and
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
guidance that supports and advances
the work of state, local, tribal and
territorial public health emergency
preparedness programs; (2) coordinates
the development of scientific guidelines
and standards for programmatic
materials within the division to provide
technical assistance and program
planning at the state, local, tribal, and
territorial level; (3) works with awardees
to advance state and local preparedness
efforts through placement of CDC field
staff within state and local public health
agencies; (4) represents the interests and
needs of the state, local, tribal, and
territorial interests on state and local
preparedness; (5) develops and ensures
effective partnerships with national
stakeholders and preparedness partners;
and (6) provides oversight and
management of division contracts,
technical assistance plan development,
training needs, response activities,
grantee awards and fiscal
accountability, and research agenda
development and compliance.
After the title and function statement
for the Applied Science and Evaluation
Branch (CGCC), Division of State and
Local Readiness (CGC), insert the
following:
Field Services Branch (CGCD). (1)
Provides scientific participation in
development and implementation of
field-based science initiatives and
strategies; (2) provides situational
awareness to CDC leadership when
activated for public health responses; (3)
provides consultation and technical
assistance to state, territorial, tribal and
local health departments in developing,
implementing and evaluating Public
Health Preparedness and Response
activities and performance in support of
CDC recommendations and those of
their host site; (4) provides support for
public health preparedness and
epidemiologic capacity at the state,
territorial, tribal, and local levels; (5)
contributes as leaders in preparedness
and epidemiology for issues including
clinical surge capacity, hospital
preparedness, and influenza response
planning; (6) participates in
development of national preparedness
and response policies and guidelines for
public health emergencies and
encourages and facilitates the transfer of
guidelines into clinical and public
health practice; (7) analyzes data to
assess progress toward achieving
program objectives and provides input
for program management and evaluation
reports for publications; (8) participates
in the development of comprehensive
evaluation methods for OPHPR
programs; (9) serves as liaison or focal
point to assist state, territorial, tribal
and local partners in linking with
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Pages 63981-63982]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25145]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[Docket ATSDR-2012-0002 ATSDR-274]
Availability of Interaction Profile for Chlorinated Dibenzo-p-
Dioxins, Polybrominated Diphenol Ethers, and Phthalates
AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR),
Department of Health and Human Services (DHHS).
ACTION: Notice of availability for public comments.
-----------------------------------------------------------------------
SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR)
within the Department of Health and Human Services announces the
availability of the interaction profile for Chlorinated Dibenzo-p-
Dioxins, Polybrominated Diphenol Ethers, and Phthalates. This
interaction profile evaluates a mixture of chemicals often found in
human blood, adipose tissue, and breast milk. The purpose of this
interaction profile is to investigate the possible joint actions of
these chemicals on endocrine, developmental, and neurobehavioral
endpoints in humans. This interaction profile has undergone external
peer-review and review by ATSDR's Interagency Workgroup on Mixtures.
[[Page 63982]]
DATES: The interaction profile was made available to the public on
September 2, 2013. The comment period will end on December 2, 2013.
ADDRESSES: You may submit comments, identified by Docket No. ATSDR-
2012-0002, by any of the following methods:
Internet: Access the Federal eRulemaking portal at https://www.regulations.gov. Follow the instructions for submitting comments.
Mail: Division of Toxicology and Human Health Sciences,
Agency for Toxic Substances and Disease Registry, 1600 Clifton Road,
NE., Mailstop F-57, Atlanta, Georgia 30333.
Instructions: All submissions received must include the agency name
and docket number for this notice. All relevant comments will be posted
without change.
FOR FURTHER INFORMATION CONTACT: Dr. Hana Pohl, Division of Toxicology
and Human Health Sciences, Agency for Toxic Substances and Disease
Registry, Mailstop F-57, 1600 Clifton Road, NE., Atlanta, Georgia
30333, telephone (888) 422-8737.
SUPPLEMENTARY INFORMATION: ATSDR develops interaction profiles for
hazardous substances found at the National Priority List (NPL) sites
under Section 104(i)(3) and (5) of the Comprehensive Environmental
Response, Compensation, and Liability Act of 1980 (CERCLA). This law
requires that ATSDR assess whether or not adequate information on
health effects is available for priority hazardous substances. Where
such information is not available or under development, ATSDR shall, in
cooperation with the National Toxicology Program, initiate a research
program to determine these health effects. The Act further directs
that, where feasible, ATSDR shall develop methods to determine the
health effects of these priority hazardous substances in combination
with other substances commonly found with them.
To carry out these legislative mandates, ATSDR has developed a
chemical mixtures program and guidance manual that outlines the latest
methods for mixtures health assessment. In addition, a series of
documents called ``interaction profiles'' is developed for certain
priority mixtures that are of special concern to ATSDR. To recommend
approaches for the exposure-based assessment of the potential hazard to
public health, an interaction profile evaluates data on the toxicology
of the whole priority mixture, if available, and on the joint toxic
action of the chemicals in the mixture.
The entire interaction profile development process is as follows:
ATSDR selects substances/chemicals for development of
interaction profiles through inter/intra agency communications
collaboration and literature reviews.
After the selection, a letter is sent to individuals and
agencies on ATSDR's mailing list providing notice of ATSDR's intent to
create an interaction profile.
A notice is posted in the Federal Register to inform the
public of ATSDR's intent to develop a particular interaction profile.
The draft interaction profile undergoes both internal and
external peer review.
A Federal Register notice announces the release of the
official draft for public comment.
ATSDR posts a link to the draft interaction profile on its
Web site, giving the public an opportunity to provide comments.
ATSDR reviews all public comments and revises the draft,
as appropriate, before issuing the final version.
Dated: October 18, 2013.
Sascha Chaney,
Acting Director, Office of Policy, Planning and Evaluation, National
Center for Environmental Health/Agency for Toxic Substances and Disease
Registry.
[FR Doc. 2013-25145 Filed 10-24-13; 8:45 am]
BILLING CODE 4163-70-P
